课题基金 / 基金详情

Chronic Ethanol Consumption and Pulmonary Immune Suppression

Chronic Ethanol Consumption and Pulmonary Immune Suppression
慢性乙醇消耗与肺部免疫抑制
批准号:
8729464
负责人:
Kevin L Legge
金额:
$17.39万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-05 至 2016-04-30

项目摘要

项目成果

Kevin L Legge的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): It is well known that alcoholics have an increased incidence of respiratory diseases. Furthermore, chronic alcoholism predisposes for severe disease following respiratory infections. Indeed, bacterial pneumonias, among the best-studied examples of this increased predisposition, result in a 2 to 7-fold greater incidence in mortality i alcoholics compared to non-alcoholic pneumonia patients. Alcohol abuse additionally increases the morbidity associated with such infections. While many studies have detailed the increase in disease severity during respiratory infections in alcoholics, much less is understood about the underlying mechanisms through which chronic ethanol (EtOH) consumption mediates this increase in disease severity or how alcohol alters pulmonary adaptive immune responses. Influenza A virus (IAV) infections represent a serious challenge to human health and are known to predispose individuals to an increased incidence of pneumonia. Interestingly, our prior studies indicate that chronic consumption of EtOH increases both influenza associated morbidity and mortality. Further, our results suggest that this increased severity of disease is related to defects or alterations in both respiratory dendritic cells (rDC) as well as influenza- specific CD8 T cell responses. Given the current threat of both epidemic and pandemic influenza as well as the ongoing threat of Streptococcal infections in alcoholics a better understanding of the alcohol induced lesions within the pulmonary adaptive immune response could lead to methodologies to boost immunity to these important human pathogens in these individuals. Therefore our long-range goal is to determine what lesions chronic EtOH induces within the respiratory adaptive immune response and determine methodologies to overcome these lesions to protect from severe and fatal disease. Within this application we will continue to use the Meadow-Cook chronic EtOH model as well as our mouse models of influenza virus (IAV) and Streptococcus (GAS) infection toward this goal. Our central hypothesis is that defects within CD8 T cells are responsible for the increased severity of respiratory infections in chronic EtOH mice. We propose the following Specific Aims: Aim 1. Determine if vaccination against IAV can enhance CD8 T cell immunity and prevent the enhanced disease associated with IAV infections during chronic EtOH consumption; Aim 2. Determine how ethanol alters the kinetics, magnitude, character of pulmonary inflammation, and CD8 T cell immunity during GAS or IAV+GAS infections. This application will not only define the defects that chronic EtOH creates in pulmonary adaptive immunity during infections with IAV and GAS but should also increase our general understanding of immunity in the presence of chronic EtOH during other respiratory infections. Furthermore, the insights learned from this application hold the potential to suggest methodologies to restore and/or boost immunity in chronic alcoholics during these diseases.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
Evaluation of hydrophobic micro-zeolite-mixed matrix membrane and integrated with acetone-butanol-ethanol fermentation for enhanced butanol production.
疏水性微沸石混合基质膜与丙酮-丁醇-乙醇发酵相结合以提高丁醇产量的评估
DOI: 10.1186/s13068-015-0288-x
发表时间: 2015
期刊: Biotechnology for biofuels
影响因子: 6.3
作者: [Xue C, Yang D, Du G, Chen L, Ren J, Bai F]
通讯作者: Bai F
A novel point mutation in RpoB improves osmotolerance and succinic acid production in Escherichia coli.
RpoB 中的一个新点突变可改善大肠杆菌的渗透压耐受性和琥珀酸产量。
DOI: 10.1186/s12896-017-0337-6
发表时间: 2017-02-13
期刊: BMC biotechnology
影响因子: 3.5
作者: [Xiao M, Zhu X, Xu H, Tang J, Liu R, Bi C, Fan F, Zhang X]
通讯作者: Zhang X
Systematic manipulation of glutathione metabolism in Escherichia coli for improved glutathione production.
系统地操纵大肠杆菌中的谷胱甘肽代谢以提高谷胱甘肽的产量。
DOI: 10.1186/s12934-016-0439-1
发表时间: 2016-02-16
期刊: Microbial cell factories
影响因子: 6.4
作者: [Zhang J, Quan C, Wang C, Wu H, Li Z, Ye Q]
通讯作者: Ye Q
DOI: 10.1186/s13068-015-0295-y
发表时间: 2015
期刊: Biotechnology for biofuels
影响因子: 6.3
作者: [Gao J, Yuan W, Li Y, Xiang R, Hou S, Zhong S, Bai F]
通讯作者: Bai F
10
    Protection and Immunity after Polyanhydride Nanoparticle Vaccination against Avian Influenza A Virus
    • 批准号:
      10584130
    • 项目类别:
    • 资助金额:
      $77.0万
    • 财政年份:
      2022
    • 负责人:
      Kevin L Legge
    • 依托单位:
    Nanovaccine-Mediated Immune Protection Against Influenza Virus
    • 批准号:
      10172830
    • 项目类别:
    • 资助金额:
      $68.09万
    • 财政年份:
      2017
    • 负责人:
      Kevin L Legge
    • 依托单位:
    Nanovaccine-Mediated Immune Protection Against Influenza Virus
    • 批准号:
      9383422
    • 项目类别:
    • 资助金额:
      $48.27万
    • 财政年份:
      2017
    • 负责人:
      Kevin L Legge
    • 依托单位:
    Chronic Alcohol Alteration of Influenza-Specific CD8 T cell Immunity and Protection
    • 批准号:
      9090516
    • 项目类别:
    • 资助金额:
      $21.77万
    • 财政年份:
      2016
    • 负责人:
      Kevin L Legge
    • 依托单位:
    海外基金